CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K‑Akt‑mTOR pathway inhibition
Affiliations: Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, P.R. China, State Key Laboratory of Microbial Metabolism, Sheng Yushou Center of Cell Biology and Immunology, School of Life Science and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, P.R. China
- Published online on: May 31, 2021 https://doi.org/10.3892/ijo.2021.5229
- Article Number: 49
Copyright: © Liao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.